Bellevue Life Sciences Acquisition Corp. (BLAC)
NASDAQ: BLAC · Real-Time Price · USD
11.27
-0.05 (-0.44%)
Dec 20, 2024, 4:00 PM EST - Market closed

BLAC Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
2.241.830.0400.03
Operating Expenses
2.241.830.0400.03
Operating Income
-2.24-1.83-0.04-0-0.03
Interest & Investment Income
2.142.78---
Pretax Income
-0.10.94-0.04-0-0.03
Income Tax Expense
0.380.54---
Net Income
-0.470.4-0.04-0-0.03
Net Income to Common
-0.470.4-0.04-0-0.03
Shares Outstanding (Basic)
68222
Shares Outstanding (Diluted)
68222
Shares Change (YoY)
-11.85%414.65%---
EPS (Basic)
-0.090.05-0.02-0.00-0.02
EPS (Diluted)
-0.090.05-0.02-0.00-0.02
Free Cash Flow
-1.96-0.82-0-0-0.03
Free Cash Flow Per Share
-0.36-0.11-0.00-0.00-0.02
EBIT
-2.24-1.83-0.04-0-0.03
Effective Tax Rate
-57.25%---
Source: S&P Capital IQ. Standard template. Financial Sources.